Cargando…
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
BACKGROUND: Helicobacter pylori (H. pylori) has infected about 50% of the world’s population and it is the main cause for peptic ulcer, gastric adenocarcinoma and even a major cause for gastric MALT lymphoma. METHODS: This study was performed in Mazandaran, Sari, situated in North of Iran. Three-hun...
Autores principales: | Kazemi Veysari, Arash, Rahimi, Ali, Maleki, Iradj, Tirgar Fakheri, Hafez, Taghvaei, Tarang, Hosseini, Vahid, Valizadeh Toosi, Seyed Mohammad, Masoumi, Danial, Bari, Zohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646372/ https://www.ncbi.nlm.nih.gov/pubmed/38024162 http://dx.doi.org/10.22088/cjim.14.4.676 |
Ejemplares similares
-
Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication
por: Yadollahi, Behsood, et al.
Publicado: (2022) -
Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015) -
A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Alhooei, Saman, et al.
Publicado: (2016) -
A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran
por: Hosseini, Vahid, et al.
Publicado: (2014) -
Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease; A Randomized Double Blind Clinical Trial
por: Taghvaei, Tarang, et al.
Publicado: (2019)